GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sun Pharmaceuticals Industries Ltd (NSE:SUNPHARMA) » Definitions » 12-1 Month Momentum %

Sun Pharmaceuticals Industries (NSE:SUNPHARMA) 12-1 Month Momentum % : 68.10% (As of May. 06, 2024)


View and export this data going back to 1995. Start your Free Trial

What is Sun Pharmaceuticals Industries 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-05-06), Sun Pharmaceuticals Industries's 12-1 Month Momentum % is 68.10%.

The industry rank for Sun Pharmaceuticals Industries's 12-1 Month Momentum % or its related term are showing as below:

NSE:SUNPHARMA's 12-1 Month Momentum % is ranked better than
88.16% of 1115 companies
in the Drug Manufacturers industry
Industry Median: -6.53 vs NSE:SUNPHARMA: 68.10

Competitive Comparison of Sun Pharmaceuticals Industries's 12-1 Month Momentum %

For the Drug Manufacturers - Specialty & Generic subindustry, Sun Pharmaceuticals Industries's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sun Pharmaceuticals Industries's 12-1 Month Momentum % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sun Pharmaceuticals Industries's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Sun Pharmaceuticals Industries's 12-1 Month Momentum % falls into.



Sun Pharmaceuticals Industries  (NSE:SUNPHARMA) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sun Pharmaceuticals Industries  (NSE:SUNPHARMA) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Sun Pharmaceuticals Industries 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Sun Pharmaceuticals Industries's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sun Pharmaceuticals Industries (NSE:SUNPHARMA) Business Description

Traded in Other Exchanges
Address
Western Express Highway, Sun House, Plot No. 201 B/1, Goregaon (East), Mumbai, MH, IND, 400 063
Sun Pharmaceuticals Industries Ltd is India's largest generic pharmaceutical manufacturer and the fourth largest in the world. The company's largest markets are the U.S. and India to make up the majority of revenue. The remaining is spread across both emerging and developed markets. In addition to generics, the company also produces and distributes name-brand formulas to specific geographies. It maintains manufacturing and research and development facilities globally to serve its markets but is primarily based in India.

Sun Pharmaceuticals Industries (NSE:SUNPHARMA) Headlines

No Headlines